Dolphin neonatal nutritional intervention trial
Faltering growth related to disease is a common paediatric problem with many potential short- and long-term consequences for growth and development. The reported prevalence in paediatric patients ranges from about 5% to 50%; those at highest risk are below the age of five.1,2 The causes of disease-related faltering growth are multi-factorial, however the most common cause is an inadequate nutritional intake, especially of energy, protein and micronutrients. Danone Nutricia Research aims to deliver optimal nutrition to support the growth, development and health of children with diseases experiencing faltering growth.
“Children can be affected by faltering growth for a number of reasons. At Danone Nutricia Research it is our aim to develop high-quality nutritional solutions that address the needs related to these specific reasons, always having individual patients in mind.”
R&D Director, Paediatric Care
Danone Nutricia ResearchView All People